TY  - GEN
AU  - Bouxsein,Mary L
AU  - Chen,Peiqi
AU  - Glass,Emmett V
AU  - Kallmes,David F
AU  - Delmas,Pierre D
AU  - Mitlak,Bruce H
TI  - Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials
SN  - 1535-1386
PY  - 2009///0708
KW  - Aged
KW  - Bone Density
KW  - drug effects
KW  - Bone Density Conservation Agents
KW  - therapeutic use
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Female
KW  - Follow-Up Studies
KW  - Fractures, Spontaneous
KW  - drug therapy
KW  - Humans
KW  - Incidence
KW  - Middle Aged
KW  - Osteoporosis, Postmenopausal
KW  - complications
KW  - Prospective Studies
KW  - Raloxifene Hydrochloride
KW  - Reference Values
KW  - Risk Assessment
KW  - Severity of Illness Index
KW  - Spinal Fractures
KW  - Teriparatide
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.2106/JBJS.H.01030
ER  -